Filter Results:
(63)
Show Results For
- All HBS Web
(241)
- People (2)
- News (63)
- Research (150)
- Multimedia (1)
- Faculty Publications (58)
Show Results For
- All HBS Web
(241)
- People (2)
- News (63)
- Research (150)
- Multimedia (1)
- Faculty Publications (58)
Page 1 of 63
Results →
Sort by
- 18 Feb 2016
- News
Challenge Aims to Speed Drug Trials Process
clinical trials process. Today, it takes at least 10 years and billions of dollars for one FDA-approved drug to move from research labs to medicine cabinets. Precision medicine will bring faster innovation, targeted medicine, and better... View Details
- 04 Sep 2014
- News
Our focus was to get drug companies to invest money in ALS
millions of dollars into research, and removed critical barriers to the development of treatments. “Our focus was to get drug companies to invest money in ALS,” says Kremer, who was diagnosed in 2004, just weeks into his first year at... View Details
- 01 Mar 2007
- News
Daniel Vasella
the test as he methodically refashioned the two old-line chemical companies with disparate corporate cultures into a single entity focused on health care and powered by an innovative approach to R&D. Today, Novartis is one of the world’s... View Details
- 19 Dec 2016
- News
Dr. Lauren Cohen Breaks All Time Squat Record
- 01 Dec 2023
- News
Wide Horizon
IP rights for suramin, a century-old drug historically used to treat African sleeping sickness, a parasitic disease, and later tested as a treatment for metastatic cancer. N of One had supported a trial by... View Details
Keywords: Dan Morrell; Photos by Sarah Wilson
- 01 Jun 2024
- News
Quantum Leap
“This is the first new kind of computer in 75 years,” says John Levy (MBA 1979), CEO of the quantum computing startup SEEQC. “And we’re building it on a chip!” Strolling through his company’s design and testing facility in Elmsford, New York, Levy looks less like a... View Details
- 31 Jan 2014
- News
Body, Heal Thyself
for the development and exclusive use of the mRNA technology to treat cardiovascular, renal, and metabolic diseases as well as cancer. "It is one of the largest-ever initial payments in a pharmaceutical industry licensing deal that does not involve a View Details
- 01 Mar 2024
- News
Alumni and Faculty Books and Podcasts
will solve real problems, from climate change and hunger to obesity and menstrual pain. They envision a future in which biotechnologists work from a platform that enables them to develop effective drugs within months for any emerging... View Details
- 31 May 2023
- News
Alumni Achievement Awards 2023
with the near-impossible job of drug discovery and development.” Back to top Depelsha Thomas McGruder (MBA 1998) COO and Treasurer, Ford Foundation Founder, Moms of Black Boys United In my solitude: “I was born in Rome, Georgia. I’m an... View Details
- 01 Jun 2023
- News
From Big Pharma to Startup
Hunter Goble (MBA 2022) did not enroll in Harvard Business School with dreams of becoming an entrepreneur. After earning his MBA, Goble intended to return to Eli Lilly to continue to work building brands and launching products. He envisioned himself leading a big,... View Details
Keywords: April White
- 01 Jun 2023
- News
Research Brief: The Best Medicine
the clinical approval process. In a survey experiment, the researchers found that 72 percent of doctors had been asked by their patients whether a new drug would “work in people like me.” Black patients and the doctors who treat them put... View Details
- 16 Sep 2016
- News
Gaining Ground on ALS
Bucket Challenge to support the Phase 3 trial of a promising investigational drug that is designed to slow the loss of lung function and muscle strength in patients with ALS. “Clinical trials cost tens to hundreds of millions of dollars,”... View Details
- 01 Mar 2016
- News
Off Script
(Thinkstock) Prescription drug spending increased by more than 13 percent in the United States in 2014, raising health insurance premiums and the ire of consumers and politicians. The reasons behind the rise are many, including the high... View Details
- 01 Jun 2018
- News
Floor It
case study with the Multiple Myeloma Research Foundation, GNS Healthcare, the Moffitt Cancer Center’s ORIEN program, and biotech firm Foundation Medicine. Rethinking Drug Trials In an adaptive platform trial, different View Details
Keywords: Julia Hanna; illustration by Mengxin Li
- 13 Oct 2016
- News
Adding Muscle to the Fight Against Disease
biotech companies—as a function of cost, time, and failure modes—tend to risk pivot on one program, one clinical trial, one outcome,” he observes. “Our company is the leader in mining muscle biology for drug discoveries that translate... View Details
Keywords: Deborah Blagg
- 24 Sep 2020
- News
The Race for a Vaccine
Moderna could create a vaccine for clinical testing in just 60 days. That was three times faster than any vaccine candidate had ever been produced. Fauci didn't believe him. An idea emerged to test Bancel’s... View Details
- 01 Sep 2008
- News
Mara Aspinall
a drug or device with an applicable test. Second, the FDA could increase the number of drugs that have specific label requirements for gene-based testing to identify the... View Details
- 20 Aug 2014
- News
With No Time to Lose
an effective biomarker—a kind of test that could measure the progression of ALS over a short period of time—did not yet exist. Without it, drug trials relied on longer, more costly observations of disease... View Details
Keywords: Margie Kelley
- 06 Dec 2021
- News
Vision: Sound Science
of scientific inquiry in gene-based hearing loss and inner-ear drug delivery: “In some infants with profound hearing impairment, there’s a mutation in one of those genes that results in loss of a protein that inner-ear cells need to... View Details
Keywords: Deb Blagg